Stephen Davis - CEO, Director at Acadia Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
ACAD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Stephen Davis since 10/6/2024

Holdings reported by Stephen Davis for Acadia Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 187K $2.85M $15.28 Aug 19, 2024 Direct
Restricted Stock Units 67.2K $1.2M $17.87 May 1, 2024 Direct Common Stock
Stock Option (Right to Buy) 286K Mar 25, 2024 Direct Common Stock

Transactions reported by Stephen Davis for Acadia Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.